Bactericidal action of Ag(0)-antithrombotic sulfated arabinogalactan nanocomposite: Coevolution of initial nanocomposite and living microbial cell to a novel nonliving nanocomposite

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 7, Issue 6, 2011, Pages 827-833

  Shurygina, Irina A ^a   Sukhov, Boris G ^b   Fadeeva, Tatiana V ^a   Umanets, Vitaly A ^a   Shurygin, Michail G ^a   Ganenko, Tatiana V ^b   Kostyro, Yana A ^b   Grigoriev, Eugene G ^a   Trofimov, Boris A ^b  

^a Scientific Center of Reconstructive and Restorative Surgery SB RAMS   (Russian Federation)

^b A E FAVORSKY IRKUTSK INSTITUTE OF CHEMISTRY   (Russian Federation)

Author keywords

Antimicrobial activity; Arabinogalactan; E. coli; Silver nanocomposite

Indexed keywords

ANTI-MICROBIAL ACTIVITY; ANTITHROMBOTIC; ARABINOGALACTAN; BACTERICIDAL ACTION; CO-EVOLUTION; DYNAMIC EQUILIBRIA; E. COLI; MEMBRANE SURFACE; METAL CLUSTER; MICROBIAL CELLS; NANO SILVER; REDOX INTERACTIONS; SILVER CATIONS; SILVER IONS;

BACTERIA; ESCHERICHIA COLI; MEMBRANES; METAL IONS; MORPHOLOGY; NANOCOMPOSITES;

SILVER;

ARABINOGALACTAN; NANOCOMPOSITE; SILVER ARABINOGALACTAN SULFATE NANOCOMPOSITE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG TRANSPORT; ELECTRON MICROSCOPY; ESCHERICHIA COLI; MORPHOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; PARTICLE SIZE; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GALACTANS; HUMANS; NANOCOMPOSITES; SILVER;

EID: 82255163068     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.03.003     Document Type: Article

References (33)

1. Nies DH Microbial heavy-metal resistance. Appl Microbiol Biotechnol 1999, 51:730-750.
2. Sondi I, Salorek-Sondi B Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004, 275:177-182.
3. Alt V, Bechert T, Steinrücke P, Wagener M, Seidel P, Dingeldein E, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004, 25:4383-4391.
4. Holt KB, Bard AJ Interaction of silver(I) ions with the respiratory chain of Escherichia coli: an electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+. Biochemistry 2005, 44:13214-13223.
5. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
6. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 2005 Jun 29, 3:6.
7. Alexandrova GP, Grishchenko LA, Fadeeva TV, Medvedeva SA, Sukhov BG, Trofimov BA Antimicrobial substance. RF Patent No. 2278669. 27.06.2006. Bull. Izobr. No. 18.
8. Panacek A, Kvítek L, Prucek R, Kolar M, Vecerova R, Pizúrova N, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem 2006, 110:16248-16253.
9. Pal S, Tak YK, Song JM Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007, 73:1712-1720.
10. Kvítek L, Panácek A, Soukupová J, Kolář M, Veceřová R, Prucek R, et al. Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). J Phys Chem 2008, 112:5825-5834.
11. Sharma VK, Yngard RA, Lin Y Silver nanoparticles: Green synthesis and their antimicrobial activities. Adv Colloid Interface Sci 2009, 145:83-96.
12. Sathishkumar M, Sneha K, Won SW, Cho C-W, Kim S, Yun Y-S Cinnamon zeylanicum bark extract and powder mediated green synthesis of nanocrystalline silver particles and its bactericidal activity. Colloids and Surfaces B: Biointerfaces 2009, 73:332-338.
13. Huanga NM, Limb HN, Radimanc S, Khiewd PS, Chiud WS, Hashime R, et al. Sucrose ester micellar-mediated synthesis of Ag nanoparticles and the antibacterial properties. Colloid Surfaces A: Physicochem Eng Aspects 2010, 353:69-76.
14. Trana HV, Tranb LD, Bac ChT, Vua HD, Nguyena ThN, Phamc DG, et al. Synthesis, characterization, antibacterial and antiproliferative activities of monodisperse chitosan- based silver nanoparticles. Colloid Surface A: Physicochem Eng Aspects 2010, 360:32-40.
15. Babua VR, Kimb Ch, Kimc S, Ahna Ch, Leea Y Development of semiinterpenetrating carbohydrate polymeric hydrogels embedded silver nanoparticles and its facile studies on E. coli. Carbohyd Polym 2010, 81:196-202.
16. Krishnaraj C, Jagan EG, Rajasekar S, Selvakumar P, Kalaichelvan PT, Mohan N Synthesis of silver nanoparticles using Acalypha indica leaf extracts and its antibacterial activity against water borne pathogens. Colloids and Surfaces B: Biointerfaces 2010, 76:50-56.
17. Faunce T, Watal A. Nanosilver and global public health: International regulatory issues. Nanomedicine 2010, 5:617-632.
18. Wright GD Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev 2005, 57:1451-1470.
19. Rao CNR, Müller A, Cheetham AK The chemistry of nanomaterials. Wiley-VCH 2004, 741.
20. Pomogailo AD, Kestelman VN Metallopolymer nanocomposites. Springer-Verlag 2005, 588.
21. Springer Handbook of Nanotechnology. Ed.: Bharat Bhushan. Springer; 2007: 1916 p.
22. Dabrowiak JC Metals in medicine 2010, 334. Wiley.
23. Polymer-based nanostructures: Medical applications. Ed.: Pavel Broz. RSC Publishing; 2010: 372 pp.
24. Sukhov BG, Ganenko TV, Ushakova IV, Kostyro YaA, Trofimov BA Nanocomposite Ag(0) as anticoagulant sulfated arabinogalactan. In Conf. ' Nanotechnologies and nanomaterials for biology and medicine' Novosibirsk 2007, 129-131.
25. Kostyro YaA, Ganenko TV, Medvedeva SA, Sukhov BG, Trofimov BA. Method for preparing sulfated derivatives of arabinogalactan possessing anticoagulating and hypolipidemic activity. RF Patent No. 2319707. 20.03.2008. Bull. Izobr. No. 8.
26. Kostyro YaA, Kovalskaya GN Sulfated arabinogalactan as the Russian analog of Sulodexide(R). Bull. ESSC SB RAMS 2008, 60:117.
27. Agsular. RF Trademark Certificate (service mark) No. 398618. 12.02.2010. Bull. Trademark Certificates 3.
28. Guidance on experimental (preclinical) study of novel pharmacological substances. Ed. V. P. Fisenko. M. Remedium; 2000: 400 pp.
29. Gimeno MC, Laguna A. Silver and gold. In: Comprehensive coordination chemistry II. 2003. Vol. 6, Part. 6.7., p. 919-83.
30. Trofimov BA, Sukhov BG, Aleksandrova GP, Medvedeva SA, Grishchenko LA, Mal'kina AG, et al. Nanocomposites with magnetic, optical, catalytic, and biologically active properties based on arabinogalactan. Doklady Chemistry 2003, 393:287-288.
31. Grishchenko LA, Medvedeva SA, Aleksandrova GP, Feoktistova LP, Sapozhnikov AN, Sukhov BG, et al. Redox reactions of arabinogalactan with silver ions and formation of nanocomposites. Russian Journal of General Chemistry 2006, 76:1111-1116.
32. Sukhov BG, Aleksandrova GP, Grishchenko LA, Feoktistova LP, Sapozhnikov AN, Proidakova OA, et al. Nanobiocomposites of noble metals on arabinogalactan basis: synthesis and structure. J Struct Chem 2007, 48:922-927.
33. Le Ru EC, Etchegoin PG. Principles of surface enhanced Raman spectroscopy and related plasmonic effects Elsevier; 2009: 663 pp.